Annual Shareholders Equity
-$14.44 M
-$23.17 M-265.26%
30 September 2023
Summary:
Outlook Therapeutics annual stockholders equity is currently -$14.44 million, with the most recent change of -$23.17 million (-265.26%) on 30 September 2023. During the last 3 years, it has fallen by -$19.05 million (-413.36%). OTLK annual shareholders equity is now -265.26% below its all-time high of $8.74 million, reached on 30 September 2022.OTLK Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$83.67 M
+$50.56 M+37.67%
30 June 2024
Summary:
Outlook Therapeutics quarterly stockholders equity is currently -$83.67 million, with the most recent change of +$50.56 million (+37.67%) on 30 June 2024. Over the past year, it has dropped by -$69.24 million (-479.54%). OTLK quarterly shareholders equity is now -271.38% below its all-time high of $48.82 million, reached on 31 December 2021.OTLK Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OTLK Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -479.5% |
| 3 y3 years | -413.4% | -1916.1% |
| 5 y5 years | -34.1% | -676.9% |
OTLK Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -265.3% | at low | -271.4% | +37.7% |
| 5 y | 5 years | -265.3% | at low | -271.4% | +37.7% |
| alltime | all time | -265.3% | +53.0% | -271.4% | +37.7% |
Outlook Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -$83.67 M(-37.7%) |
| Mar 2024 | - | -$134.24 M(+451.4%) |
| Dec 2023 | - | -$24.34 M(+68.6%) |
| Sept 2023 | -$14.44 M(-265.3%) | -$14.44 M(+162.4%) |
| June 2023 | - | -$5.50 M(-152.5%) |
| Mar 2023 | - | $10.49 M(-33.4%) |
| Dec 2022 | - | $15.76 M(+80.4%) |
| Sept 2022 | $8.74 M(+89.6%) | $8.74 M(-56.5%) |
| June 2022 | - | $20.08 M(-44.2%) |
| Mar 2022 | - | $35.96 M(-26.3%) |
| Dec 2021 | - | $48.82 M(+959.7%) |
| Sept 2021 | $4.61 M(+63.0%) | $4.61 M(-63.9%) |
| June 2021 | - | $12.75 M(-38.3%) |
| Mar 2021 | - | $20.65 M(-297.1%) |
| Dec 2020 | - | -$10.47 M(-470.6%) |
| Sept 2020 | $2.83 M | $2.83 M(-74.2%) |
| June 2020 | - | $10.97 M(-153.4%) |
| Mar 2020 | - | -$20.52 M(-19.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | - | -$25.41 M(+135.9%) |
| Sept 2019 | -$10.77 M(-48.2%) | -$10.77 M(+692.9%) |
| June 2019 | - | -$1.36 M(-94.1%) |
| Mar 2019 | - | -$23.05 M(+7.3%) |
| Dec 2018 | - | -$21.47 M(+3.2%) |
| Sept 2018 | -$20.81 M(-32.3%) | -$20.81 M(+124.6%) |
| June 2018 | - | -$9.26 M(-39.3%) |
| Mar 2018 | - | -$15.27 M(+93.3%) |
| Dec 2017 | - | -$7.90 M(-74.3%) |
| Sept 2017 | -$30.73 M(+494.0%) | -$30.73 M(+6.2%) |
| June 2017 | - | -$28.94 M(+7.8%) |
| Mar 2017 | - | -$26.85 M(+23.0%) |
| Dec 2016 | - | -$21.83 M(+322.0%) |
| Sept 2016 | -$5.17 M(-81.9%) | -$5.17 M(-430.9%) |
| June 2016 | - | $1.56 M(-107.6%) |
| Mar 2016 | - | -$20.47 M(+70.2%) |
| Dec 2015 | - | -$12.02 M(-58.0%) |
| Sept 2015 | -$28.60 M(0.0%) | -$28.60 M |
| Sept 2014 | -$28.60 M | - |
FAQ
- What is Outlook Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly shareholders equity year-on-year change?
What is Outlook Therapeutics annual stockholders equity?
The current annual shareholders equity of OTLK is -$14.44 M
What is the all time high annual shareholders equity for Outlook Therapeutics?
Outlook Therapeutics all-time high annual stockholders equity is $8.74 M
What is Outlook Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of OTLK is -$83.67 M
What is the all time high quarterly shareholders equity for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly stockholders equity is $48.82 M
What is Outlook Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, OTLK quarterly stockholders equity has changed by -$69.24 M (-479.54%)